Document is current
Any future updates will be listed below
-
Authors
De Filippis, Sergio
Vita, Antonio
Cuomo, Alessandro
Amici, Emanuela
Giovanetti, Valeria
Lombardozzi, Ginevra
Pardossi, Simone
Altieri, Luca
Cicale, Andrea
Dosoli, Marisa
Galluzzo, Alessandro
Invernizzi, Elena
Rodigari, Paola
Mascagni, Patrizia
Santini, Claudia
Falsetto, Nathalie
Manes, Marta Antonia
Micillo, Marco
Fagiolini, Andrea
-
Funding
Funding for this research was provided by:
The study was funded by Angelini Pharma S.p.A.
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 27 October 2024
First Online: 5 November 2024
Declarations
:
: The study was approved by the ethics committee at each participating centre (Comitato Etico Regione Toscana – Area Vasta Sud Est; Comitato Etico di Brescia; Comitato Etico Lazio 2) and performed in accordance with good clinical practice and local regulatory requirements. Written informed consent was obtained from all patients and consent could be withdrawn at any time.
: Not applicable.
: Alessandro Cuomo is /has been a consultant and/or a speaker and/or has received research grants from Angelini, Boheringer Ingelheim, Italfarmaco, GSK, Lundbeck, Janssen, Otsuka, Pfizer, Recordati, Rovi, Sunovion, Teva, Viatris. Andrea Fagiolini is /has been a consultant and/or a speaker and/or has received research grants from Angelini, Boheringer Ingelheim, Idorsia, Italfarmaco, Lundbeck, Janssen, Medicamenta, Medifar, Otsuka, Pfizer, Recordati, Rovi, Sunovion, Teva, Viatris. Patrizia Mascagni and Claudia Santini are Hippocrates Research S.r.l. employees (CRO delegated for study conduction). Marco Micillo, Marta Antonia Manes, Nathalie Falsetto are Angelini S.p.A. employees. The other authors declare no conflict of interest.
